1,956 results match your criteria: "Clinical Director[Affiliation]"
Aust J Gen Pract
July 2024
MBBS, FRACP, FCSANZ, Clinical Director, Coronary Care Unit, Gold Coast University Hospital, Southport, Qld; Associate Professor, Griffith University School of Medicine, Southport, Qld; Honorary Adjunct Associate Professor, Faculty of Health science and Medicine, Bond University, Robina, Qld.
Background: Cardiovascular diseases (CVDs) pose significant global health challenges, with genetics increasingly recognised as a key factor alongside traditional risk factors. This presents an opportunity for general practitioners (GPs) to refine their approaches.
Objective: This article explores the impact of genetics on CVDs and its implications for GPs.
Aust J Gen Pract
July 2024
MBBS, FRACP, FCSANZ, Clinical Director, Coronary Care Unit, Gold Coast University Hospital, Southport, Qld; Associate Professor, Griffith University School of Medicine, Southport, Qld; Honorary Adjunct Associate Professor, Faculty of Health science and Medicine, Bond University, Robina, Qld.
Background: Approximately 50% of children experience a cardiac murmur at some point in their lives; <1% of these murmurs are attributed to congenital heart disease (CHD). Cardiac murmur might be the first clinical sign of a significant CHD in children. Despite careful routine medical examinations at birth, approximately 50% of CHD cases could remain unrecognised.
View Article and Find Full Text PDFAust J Gen Pract
July 2024
FRACP, BSc, MBBS, Staff Cardiologist, Electrophysiologist, Department of Cardiology, Gold Coast University Hospital, Gold Coast, Qld; Senior Lecturer, School of Medicine and Dentistry, Griffith University, Gold Coast, Qld.
Background: Aortic stenosis (AS) remains one of the most commonly encountered valvular pathologies. Medical management does not alter the progression of the disease, making assessment of severity and timing of referral for valve replacement the most important aspects of caring for patients with AS.
Objective: To review the contemporary management of AS, including signs and symptoms, echocardiography and decision making in management.
Aust J Gen Pract
July 2024
MBBS, FRACP, FCSANZ, Clinical Director, Coronary Care Unit, Gold Coast University Hospital, Southport, Qld; Associate Professor, Griffith University School of Medicine, Southport, Qld; Honorary Adjunct Associate Professor, Faculty of Health science and Medicine, Bond University, Robina, Qld.
Background: Chest pain is a common symptom in the community, with underlying causes ranging from benign musculoskeletal pain to life-threatening cardiac events. It is a challenging presentation for healthcare providers, because the aetiology is not always immediately apparent. Chest pain can also cause significant anxiety for patients, leading to increased healthcare utilisation and costs.
View Article and Find Full Text PDFTransl Psychiatry
July 2024
Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA.
J Clin Oncol
September 2024
Division of Medical Oncology, Department of Internal Medicine, College of Medicine, The Ohio State University, and the Comprehensive Cancer Center, Columbus, OH.
Purpose: Cabozantinib and nivolumab (CaboNivo) alone or with ipilimumab (CaboNivoIpi) have shown promising efficacy and safety in patients with metastatic urothelial carcinoma (mUC), metastatic renal cell carcinoma (mRCC), and rare genitourinary (GU) tumors in a dose-escalation phase I study. We report the final data analysis of the safety, overall response rate (ORR), progression-free survival (PFS), and overall survival (OS) of the phase I patients and seven expansion cohorts.
Methods: This is an investigator-initiated, multicenter, phase I trial.
Psychiatry Res
September 2024
Division of Population Health Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
Int J Palliat Nurs
June 2024
Head of Clinical Governance, Treat-it Clinic, Kanabo, UK.
J Am Coll Radiol
December 2024
Harvard-MIT Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts; Associate Chair of Faculty Affairs, Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts; Director of Translational Neuro MR Imaging, Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, Massachusetts. Electronic address:
Am J Physiol Heart Circ Physiol
August 2024
Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States.
Williams-Beuren syndrome (WBS) is a rare genetic condition caused by a chromosomal microdeletion at 7q11.23. It is a multisystem disorder characterized by distinct facies, intellectual disability, and supravalvar aortic stenosis (SVAS).
View Article and Find Full Text PDFPrim Dent J
June 2024
Robert Spielman Undergraduate dental student, Department of General Dentistry and Comprehensive Care, New York University College of Dentistry, New York, USA.
External cervical root resorption may be occasionally mistaken for root caries and vice versa. Radiographical and clinical differential diagnoses of cervical root resorption and root caries are essential for correct treatment planning and a successful treatment outcome. This article reviews the contemporary literature and summarises the prevailing professional consensus pertaining to external cervical root resorption.
View Article and Find Full Text PDFAm J Transl Res
May 2024
Department of Radiation Oncology, GenesisCare Madrid Clinical Director, San Francisco de Asis and La Milagrosa Hospitals, National Chair of Research and Clinical Trials GenesisCare, Madrid, Spain.
Liquid biopsy is an innovative approach that provides a more complete understanding of treatment response and prognosis in monitoring metastatic prostate cancer. It complements invasive tissue biopsy and involves the assessment of various biomarkers in body fluids such as blood, semen, and urine. Liquid biopsy analyzes circulating tumor cells, extracellular vesicles, circulating tumor DNA, and the secretome.
View Article and Find Full Text PDFAustralas Psychiatry
August 2024
School of Medicine, University of Wollongong, Wollongong, NSW, Australia.
Objective: To determine whether a brief educational intervention for Junior Medical Officers (JMOs), using teaching methods aimed at achieving higher outcomes on Bloom's Taxonomy, significantly improved participant confidence and knowledge in decision making about restrictive care.
Method: JMOs received a teaching session on restrictive medical and mental health care. Groups were randomly assigned to either sessions including a component of modern pedagogical interventions (Think-Pair-Share and SNAPPS), or sessions including a control period focusing on reviewing a condensed summary of relevant information.
Aust J Rural Health
October 2024
Emergency Services Senior Medical Officer, Northeast Health Wangaratta, Wangaratta, Victoria, Australia.
Introduction: In 2018, the Australasian College for Emergency Medicine (ACEM) and the Royal College of Pathologists of Australasia (RCPA) produced a guideline to encourage appropriate pathology requesting in the Emergency Department (ED).
Objective: To assess adherence to the ACEM/RCPA pathology testing guideline in a regional ED.
Methods, Design, Setting And Participants: This was a retrospective observational study conducted at a regional Australian ED over 7 days.
PLoS One
June 2024
Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, NIH, Baltimore, MD, United States of America.
Individuals with Alcohol Use Disorder (AUD) typically have comorbid chronic health conditions, including anxiety and depression disorders, increased sleep disruption, and poor nutrition status, along with gut microbial dysbiosis. To better understand the effects of gut dysbiosis previously shown in individuals with AUD, gut microbiome and metabolome were investigated between three cohorts. Two groups of individuals with AUD included treatment-seeking newly abstinent for at least six weeks (AB: N = 10) and non-treatment-seeking currently drinking (CD: N = 9) individuals.
View Article and Find Full Text PDFAm J Drug Alcohol Abuse
June 2024
Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, USA.
describes amplified emotional and motivational withdrawal due to addiction-related sensitization of brain-stress-systems. Hyperkatifeia has been proposed as a target for addiction treatment development. However, translation of basic research in this area will require new tools designed to measure and related phenomena outside of laboratory settings.
View Article and Find Full Text PDFBr J Nurs
June 2024
Research and Development Director, Royal Devon University Healthcare NHS Foundation Trust/Clinical Director, NIHR PRC Exeter/Honorary Clinical Professor, Faculty of Health and Life Sciences, University of Exeter/Visiting Professor of Clinical Nursing, School of Nursing and Midwifery, University of Plymouth.
Effective integration of research within healthcare organisations is recognised to improve outcomes. A research strategy within a hospital Trust in South West England was revised, following the launch of a national Chief Nursing Officer (CNO) strategy that promotes research engagement and activity. The aim was to develop, implement and evaluate this revised strategic plan for research.
View Article and Find Full Text PDFBr J Nurs
June 2024
Quality Improvement Education Lead, Centre for Sustainable Healthcare, Oxford.
Background: The NHS is the first public body globally to commit to net zero.
Aim: This study aimed to explore the environmental sustainability impact of a hospital scholarship programme.
Method: A sustainable quality improvement value framework was used to measure the programme's environmental, social and financial effects.
Nat Rev Gastroenterol Hepatol
September 2024
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Most patients with alcohol-associated liver disease (ALD) engage in heavy drinking defined as 4 or more drinks per day (56 g) or 8 (112 g) or more drinks per week for women and 5 or more drinks per day (70 g) or 15 (210 g) or more drinks per week for men. Although abstinence from alcohol after diagnosis of ALD improves life expectancy and reduces the risk of decompensation of liver disease, few studies have evaluated whether treatment of alcohol use disorders will reduce progression of liver disease and improve liver-related outcomes. In November 2021, the National Institute of Alcohol Abuse and Alcoholism commissioned a task force that included hepatologists, addiction medicine specialists, statisticians, clinical trialists and members of regulatory agencies to develop recommendations for the design and conduct of clinical trials to evaluate the effect of alcohol use, particularly treatment to reduce or eliminate alcohol use in patients with ALD.
View Article and Find Full Text PDFNeurobiol Stress
July 2024
Human Psychopharmacology Laboratory, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, USA.
Stress plays a well-documented role in alcohol consumption and the risk for developing alcohol use disorder. The concept of resilience - coping with and successfully adapting to stressful life experiences - has received increasing attention in the field of addiction research in recent decades, and there has been an accumulation of evidence for resilience as a protective factor against problematic alcohol consumption, risk for alcohol use disorder, disorder severity, and relapse. The conceptual and methodological approaches used in the generation of this evidence vary considerably across investigations, however.
View Article and Find Full Text PDFmedRxiv
May 2024
Section of Human Biochemical Genetics, Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Nurs Outlook
August 2024
Office of Research on Women's Health, National Institutes of Health, Bethesda, MD.
The National Institute of Health (NIH) policy, Consideration of Sex as a Biological Variable (SABV) in NIH-funded Research (2015), focuses on the expectation that researchers account for the influence of SABV in vertebrate animal and human studies and provide a strong justification for single-sex investigations. When SABV is considered in the research design, data analyses, and reporting, the rigor and reproducibility of the research are elevated and inform best practices and precision health for all people. Additional recommendations include the appropriate use of terminology, integration into curricula, intersection with social determinants of health, and application of sex and gender equity guidelines when disseminating research.
View Article and Find Full Text PDFToxins (Basel)
May 2024
Office of the Clinical Director, Intramural Research Program, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.
Nat Commun
May 2024
Section for Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Human immunodeficiency virus type-1 (HIV-1) is responsible for significant mortality and morbidity worldwide. Despite complete control of viral replication with antiretrovirals, cells with integrated HIV-1 provirus can produce viral transcripts. In a cross-sectional study of 84 HIV+ individuals of whom 43 were followed longitudinally, we found that HIV-1 RNAs are present in extracellular vesicles (EVs) derived from cerebrospinal fluid and serum of all individuals.
View Article and Find Full Text PDFJ Addict Med
October 2024
From the Section of Sensory Science and Metabolism, National Institute on Alcohol Abuse and Alcoholism, and National Institute of Nursing Research, National Institutes of Health, Bethesda, MD (KA, PVJ); Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD (JWL, MLS, DG, ND); Human Psychopharmacology Laboratory, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD (BLS, VAR); Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Rockville, MD (DG); Clinical NeuroImaging Research Core, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD (RM); Department of Neurology, Indiana University School of Medicine, Indianapolis, IN (DAK); and Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, National Institute on Alcohol Abuse and Alcoholism, Division of Intramural Clinical and Biological Research and National Institute on Drug Abuse Intramural Research Program, National Institutes of Health (LL).